Bharat Biotech inks pact with WU's School of Medicine for COVID-19 intranasal vaccine

Bharat Biotech on Wednesday signed a licensing agreement with Washington University School of Medicine in St Louis for a novel "chimp-adenovirus" (Chimpanzee adenovirus), single dose intranasal vaccine for COVID-19. According to a press release issued by the city-based vaccine maker, Bharat Biotech owns the rights to distribute the vaccine in all markets except the US, Japan and Europe.

from IndiaTV India: Google News Feed https://ift.tt/2FTj9m7

Get Breaking news, Live news, and latest news from India and around the world on INDILIVENEWS.com, which are in the interest of nation and humanity. Like us on Facebook or Follow us on Twitter and Reddit for the latest news blog and live news update